Correlation Between IXUP and Telix Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both IXUP and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IXUP and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between IXUP and Telix Pharmaceuticals, you can compare the effects of market volatilities on IXUP and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IXUP with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of IXUP and Telix Pharmaceuticals.

Diversification Opportunities for IXUP and Telix Pharmaceuticals

-0.35

Correlation Coefficient

IXUP  Telix Pharmaceuticals

Very good diversification

The 3 months correlation between IXUP and Telix is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding IXUP and Telix Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and IXUP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IXUP are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of IXUP i.e., IXUP and Telix Pharmaceuticals go up and down completely randomly.

Pair Corralation between IXUP and Telix Pharmaceuticals

Assuming the 90 days trading horizon IXUP is expected to under-perform the Telix Pharmaceuticals. In addition to that, IXUP is 3.12 times more volatile than Telix Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Telix Pharmaceuticals is currently generating about 0.08 per unit of volatility. If you would invest  2,467  in Telix Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  302.00  from holding Telix Pharmaceuticals or generate 12.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

IXUP  vs.  Telix Pharmaceuticals

IXUP

Risk-Adjusted Performance

Very Weak

Over the last 90 days IXUP has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Telix Pharmaceuticals

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Telix Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with IXUP and Telix Pharmaceuticals

The main advantage of trading using opposite IXUP and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IXUP position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.

The idea behind IXUP and Telix Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.